De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1

被引:9
作者
Ben-Uliel, Shulamit Fluss [1 ]
Zoabi, Faten Habrat [1 ]
Slavin, Moriya [2 ]
Sibony-Benyamini, Hadas [1 ]
Kalisman, Nir [2 ]
Qvit, Nir [1 ]
机构
[1] Bar Ilan Univ, Azrieli Fac Med Galilee, IL-1311502 Safed, Israel
[2] Hebrew Univ Jerusalem, Inst Life Sci, IL-9190401 Jerusalem, Israel
基金
以色列科学基金会;
关键词
Pink1; mitophagy; bioactive peptides; peptidomimetics; backbone cyclization; protein-protein interactions; protein-peptide interactions; therapeutic peptides; mitochondria; molecular probes; CONFORMATIONAL CONSTRAINT; PEPTIDE-SYNTHESIS; PROTEIN; INHIBITOR;
D O I
10.3390/ijms23116076
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitochondria play central roles in maintaining cellular metabolic homeostasis, cell survival and cell death, and generate most of the cell's energy. Mitochondria maintain their homeostasis by dynamic (fission and fusion) and quality control mechanisms, including mitophagy, the removal of damaged mitochondria that is mediated mainly by the Pink1/Parkin pathway. Pink1 is a serine/threonine kinase which regulates mitochondrial function, hitherto many molecular mechanisms underlying Pink1 activity in mitochondrial homeostasis and cell fate remain unknown. Peptides are vital biological mediators that demonstrate remarkable potency, selectivity, and low toxicity, yet they have two major limitations, low oral bioavailability and poor stability. Herein, we rationally designed a linear peptide that targets Pink1 and, using straightforward chemistry, we developed molecular probes with drug-like properties to further characterize Pink1. Initially, we conjugated a cell-penetrating peptide and a cross-linker to map Pink1's 3D structure and its interaction sites. Next, we conjugated a fluorescent dye for cell-imaging. Finally, we developed cyclic peptides with improved stability and binding affinity. Overall, we present a facile approach to converting a non-permeable linear peptide into a research tool possessing important properties for therapeutics. This is a general approach using straightforward chemistry that can be tailored for various applications by numerous laboratories.
引用
收藏
页数:18
相关论文
共 50 条
[1]  
ALETRAS A, 1995, INT J PEPT PROT RES, V45, P488
[2]   PINK1 and Parkin: team players in stress-induced mitophagy [J].
Bader, Verian ;
Winklhofer, Konstanze F. .
BIOLOGICAL CHEMISTRY, 2020, 401 (6-7) :891-899
[3]  
Bourel L, 2000, J PEPT SCI, V6, P264, DOI 10.1002/1099-1387(200006)6:6<264::AID-PSC248>3.3.CO
[4]  
2-1
[5]  
Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185
[6]   A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats [J].
Ferreira, Julio C. B. ;
Campos, Juliane C. ;
Qvit, Nir ;
Qi, Xin ;
Bozi, Luiz H. M. ;
Bechara, Luiz R. G. ;
Lima, Vanessa M. ;
Queliconi, Bruno B. ;
Disatnik, Marie-Helene ;
Dourado, Paulo M. M. ;
Kowaltowski, Alicia J. ;
Mochly-Rosen, Daria .
NATURE COMMUNICATIONS, 2019, 10 (1)
[7]  
Fischer E., 1894, Chem. Ber, V27, P2985, DOI [DOI 10.1002/CBER.18940270364, 10.1002/cber.18940270364]
[8]   Correcting mitochondrial fusion by manipulating mitofusin conformations [J].
Franco, Antonietta ;
Kitsis, Richard N. ;
Fleischer, Julie A. ;
Gavathiotis, Evripidis ;
Kornfeld, Opher S. ;
Gong, Guohua ;
Biris, Nikolaos ;
Benz, Ann ;
Qvit, Nir ;
Donnelly, Sara K. ;
Chen, Yun ;
Mennerick, Steven ;
Hodgson, Louis ;
Mochly-Rosen, Daria ;
Dorn, Gerald W., II .
NATURE, 2016, 540 (7631) :74-+
[9]   CELLULAR UPTAKE OF THE TAT PROTEIN FROM HUMAN IMMUNODEFICIENCY VIRUS [J].
FRANKEL, AD ;
PABO, CO .
CELL, 1988, 55 (06) :1189-1193
[10]   BACKBONE CYCLIZATION - A NEW METHOD FOR CONFERRING CONFORMATIONAL CONSTRAINT ON PEPTIDES [J].
GILON, C ;
HALLE, D ;
CHOREV, M ;
SELINGER, Z ;
BYK, G .
BIOPOLYMERS, 1991, 31 (06) :745-750